Inspire Medical Systems, Inc. to Present at the 2020 Stifel Virtual Healthcare Conference
MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Year: 2020
Cocrystal Pharma Selected to Present at the World Antiviral Conference
BOTHELL, WA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
Phase 1 trials evaluating CTI-1601 as a treatment for Friedreich’s ataxia on track for topline data in 1H 2021 Received...
Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
WATERTOWN, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics...
Arbutus to Present at Jefferies Virtual London Healthcare Conference
WARMINSTER, Penn., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
X4 Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference
BOSTON, Nov. 10, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
Cue Biopharma to Host Business Update Call and Webcast
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class...
NeuBase Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17
PITTSBURGH, Nov. 10, 2020 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating...
ORYZON Receives Approval to Start PORTICO Phase IIb Trial with Vafidemstat in Borderline Personality Disorder
Clinical Trial Application approved by Spanish Drug Agency Builds on clinical data from two Phase IIa trials Primary objectives: reduction...
Healthwise Recognized for Plain Language Excellence with 2020 ClearMark Awards
Healthwise health education awarded top honors BOISE, Idaho, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Healthwise announced today that it captured...
Selecta Biosciences to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
WellSpan Health Partners with VisitPay to Improve the Patient Financial Experience
200+ care locations to benefit from optimized and consolidated billing experience, setting a heightened standard for financial transparency BOISE, Idaho,...
Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference
MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
Establishment Labs to Participate in Two Upcoming Investment Conferences
SANTA BARBARA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused...
TCR² Therapeutics Announces Partnership with ElevateBio to Expand TC-210 Manufacturing Capacity
- ElevateBio BaseCamp to support anticipated TC-210 Phase 2 clinical trial demand CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) --...
AzurRx BioPharma Identifies Asymchem as Potential Partner of Choice for MS1819 Phase 3 Clinical Trial Drug Production
DELRAY BEACH, Fla., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing...
Innovative Cellular Therapeutics to Participate in Upcoming Investor Conferences
ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive...
Aerpio Reports Third Quarter 2020 Financial Results and Provides Business Update
Enrollment completed in the 28-day Phase 2 razuprotafib glaucoma trial; topline data expected to be reported in December 2020 or...
Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
Applied Molecular Transport Announces Publication of Preclinical Data Demonstrating Potential of Novel Oral IL-10 Biologic Therapeutic (AMT-101) for Inflammatory Diseases in The Journal of Immunology
- AMT-101 (oral fusion protein of hIL-10 and AMT carrier) rapidly and efficiently transports through intestinal epithelia in healthy and...